Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

By S. Grundy, J. Cleeman, S. Daniels, K. Donato, R. Eckel, B. Franklin, D. Gordon, Ronald M. Krauss, P. Savage, Sidney C. Smith and 2 more. Circulation, 2005

5,501 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/a887b246f763e6fb67f2ed6c596a8595af955e27

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Jaspinder Kaur

In Endocrinology, Diabetes and Metabolism

1. Jaspinder Kaur

In Surgery

1. Jaspinder Kaur

Citations in the corpus

• Pathophysiology of Type 2 Diabetes Mellitus (2020, background): “T2DM and IR impair metabolism and clearance of chylomicrons and VLDLs. Activation of CETP promotes an exchange of TG out of RLPs and incorporates CE from HDL and LDL particles leading to reduced levels of circulating HDL-C and an increase in the more atherogenic sdLDL particles (lower panel).”
• A Comprehensive Review on Metabolic Syndrome (2014, background): “The metabolic syndrome has its origins in 1920 when Kylin, a Swedish physician, demonstrated the association of high blood pressure (hypertension), high blood glucose (hyperglycemia), and gout [12].”